These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. GAA deficiency disrupts distal airway cells in Pompe disease. El Haddad L; Lai E; Murthy PKL; Biswas DD; Soufny R; Roger AL; Tata PR; ElMallah MK Am J Physiol Lung Cell Mol Physiol; 2023 Sep; 325(3):L288-L298. PubMed ID: 37366541 [TBL] [Abstract][Full Text] [Related]
5. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988 [TBL] [Abstract][Full Text] [Related]
6. Glycogenosome accumulation in the arrector pili muscle in Pompe disease. Katona I; Weis J; Hanisch F Orphanet J Rare Dis; 2014 Feb; 9():17. PubMed ID: 24495340 [TBL] [Abstract][Full Text] [Related]
7. The respiratory neuromuscular system in Pompe disease. Fuller DD; ElMallah MK; Smith BK; Corti M; Lawson LA; Falk DJ; Byrne BJ Respir Physiol Neurobiol; 2013 Nov; 189(2):241-9. PubMed ID: 23797185 [TBL] [Abstract][Full Text] [Related]
8. Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations. Case LE; Beckemeyer AA; Kishnani PS Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):69-79. PubMed ID: 22252989 [TBL] [Abstract][Full Text] [Related]
14. Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). Ripolone M; Violano R; Ronchi D; Mondello S; Nascimbeni A; Colombo I; Fagiolari G; Bordoni A; Fortunato F; Lucchini V; Saredi S; Filosto M; Musumeci O; Tonin P; Mongini T; Previtali S; Morandi L; Angelini C; Mora M; Sandri M; Sciacco M; Toscano A; Comi GP; Moggio M Neuropathol Appl Neurobiol; 2018 Aug; 44(5):449-462. PubMed ID: 28574618 [TBL] [Abstract][Full Text] [Related]
15. The impact of antibodies in late-onset Pompe disease: a case series and literature review. Patel TT; Banugaria SG; Case LE; Wenninger S; Schoser B; Kishnani PS Mol Genet Metab; 2012 Jul; 106(3):301-9. PubMed ID: 22613277 [TBL] [Abstract][Full Text] [Related]
16. The emerging phenotype of late-onset Pompe disease: A systematic literature review. Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884 [TBL] [Abstract][Full Text] [Related]